Pregnancy-associated plasma protein A (PAPP-A) and soluble receptor for advanced glycation end products (sRAGE) intra- and inter-individual variability in chronic hemodialysis patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 4, 2012, Pages 296-303

  Míková, Blanka ^a   Jarolímková, Eva ^a   Benáková, Hana ^a   Dohnal, Luděk ^a   Tesař, Vladimír ^a   Zima, Tomáš ^a   Kalousová, Marta ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cardiovascular disease; End stage renal disease; Hemodialysis; PAPP A; sRAGE; Variability

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHOLESTEROL; HEMOGLOBIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TRANSFERRIN;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LEUKOCYTE COUNT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS; RENAL DIALYSIS; TRANSFERRIN;

EID: 84862838628     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.663099     Document Type: Article

References (40)

1. Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272-80.
2. Kalousova M, Sulkova S, Fialova L, Soukupova J, Malbohan IM, Spacek P, Braun M, Mikulikova L, Fortova M, Horejsi M, Tesar V, Zima T. Glycoxidation and infl ammation in chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:2577-81.
3. Hansson GK. Infl ammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
4. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K,Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H.Signifi cance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratifi cation for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009;54:601-8.
5. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S,Simoons ML, Zeiher AM and CAPTURE Study Investigators.Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic infl ammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005;45:229-37.
6. Hudson BI, Harja E, Moser B, Schmidt AM. Soluble receptor for adVanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein? Arterioscler Thromb Vasc Biol 2005;25:879-82.
7. Pullerits R, Bokarewa M, Dahlberg R, Tarkowski A.Decreased levels of soluble receptor for adVanced glycation end products in patients with rheumatoid arthritis indicating defi cient infl ammatory control. Arthritis Res Ther 2005;7:817-24.
8. Bunn RC, FowlkesJL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol. Metab. 2003;14:176-81.
9. Conti E, Andreotti F, Zuppi C. Pregnancy-associated plasma protein-A as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 2004;109:211-2.
10. Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F,Zuppi C, Andreotti F. Insulin-like growth factor-1 as vascular protective factor. Circulation 2004;110:2260-5.
11. Andreotti F, Becker RC. Atherothrombotic disorDers: new insights from hematology. Circulation 2005;111:1855-63.
12. Capoluongo E, Ameglio F, Lulli P, Minucci A, Santonocito C, Concolino P, Di Stasio E, Boccaci S, Vendettuoli V,Giuratrabocchetta G, De Cunto A, Tana M, Romagnoli C,Zuppi C, Vento G. Epithelial lining fl uid free IGF-I-to- PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol. Metab. 2007;292:308-13.
13. C rea F, Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend or foe? Eur Heart J 2005;26:2075-6.
14. Kalousova M, Horejsi M, Fialova L, Soukupova J, Sulkova S, Malbohan I, Tesar V, Zima T. Increased levels of pregnancy- associated plasma protein A (PAPP-A) are associated with mortality of haemodialysis patients: preliminary results.Blood Purif 2004;22:298-300.
15. Etter C, Straub Y, Hersberger M, Räz HR, Kistler T,Kiss D, Wüthrich RP, Gloor HJ, Aerne D, Wahl P, Klaghofer R, Ambühl PM. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J 2010;31:354-9.
16. á M, Benák ová H, Kubena AA, Dusilov á- Sulkov á S, Tesar? V, Zima T. Pregnancy-associated plasma protein A (PAPP-A) as an independent mortality predictor in longterm hemodialysis patients. Kidney Blood Press Res 2012;35:192-201.
17. Schmidt AM, Yanc SD, Yana SF, Stern DM. The biology of the receptor for adVanced glycation end products and its ligand. Biochim Biophys Acta 2000;1498:99-111.
18. Basta G. Receptor for adVanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications.Atherosclerosis 2008;196:9-21.
19. Kalousová M, Ho d'k ová M, KazDerová M, Fialová J, Tesar? V,Dusilová-Sulková S, Zima T. Soluble receptor for adVanced glycation end products in patients with decreased renal function.Am J Kidney Dis 2006;47:406-11.
20. Kalousová M, Já c hymová M, Mestek O, Hodková M,KazDerov á M, Tesar? V, Zima T. Receptor for adVanced glycation end products-soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 2007;22:2020-6.
21. Geroldi D, Falcone C, Emanuele E, D'A ngelo A, Calcagnino M, Buzzi M, Scioli GA, Fogari R. Decreased plasma levels of soluble receptor for adVanced glycation end-products in patients with essential hypertension. J Hypertens 2005;23:1725-9.
22. Park L, Roman KG, Kee KJ, Lu Y, Ferran LJ Jr, Chow WS,Stern D, Schmidt AM. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for adVanced glycation end products. Nat Med 1998;4:1025-31.
23. Armitage P, Berry G. Statistical methods in medical research,3rd edn. London: Blackwell Science, 1994.
24. T sirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I,Lagouranis A, Chatzipanagiotou S, Nicolaou C. The variability and accurate assessment of microinfl ammation in haemodialysis patients. Nephrol Dial Transplant 2004;19:150-7.
25. Kalousová M, Bartošová K, Zima T, Skibová J, Teplan V,Viklick ý O. Pregnancy-associated plasma protein A and soluble receptor for adVanced glycation end products after kidney transplantation. Kidney Blood Press Res 2007;30:31-7.
26. Fialova L, Kalousova M, Soukupova J, Sulkova S, Merta M,Jelinkova E, Horejsi M, Sramek P, Malbohan I, Mikulikova L, Tesar V, Zima T. Relationship of pregnancy-associated plasma protein A (PAPP-A) to renal function and dialysis modalities. Kidney Blood Press Res 2004;27:88-95.
27. Cosin-Sales J, Christiansen M, Karminski P, Oxvig C,Overgaard MT, Cole D, Holt DW, Kaski JC. Pregnancyassociated plasma protein A and its endogenous inhibitor,the proform of eosinophil major basic protein (proMBP),are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004;109:1724-8.
28. Mueller T, Dieplinger B, Poelz W, Haltmayer M. Increased pregnancy-associated plasma protein A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study. Clin Chem 2006;52:1096-103.
29. Neyra NR, Hakim RM, Shyr Y, Ikitzler TA. Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients. J Ren Nutr 2000;10:184-90.
30. Gross S, Van Ree RM, Oterdoom LH, de Vries APJ, Van Son WJ, de Jong PE, Navis GJ, Zuurman MW, Bierhaus A, Gans ROB, Bakker SJL. Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients.Transplantation 2007;84:659-63.
31. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Buchler MW, Weigand MA. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008;147:79-83.
32. Nakamura K, Yamagishi S, Adachi H, Matsui T,Kurita-Nakamura Y, Matsui T, Yoshida T, Imaizumi T.Serum levels of sRAGE, the soluble form of receptor for adVanced glycation end products, are associated with infl ammatory markers in patients with type 2 diabetes. Mol Med 2007;13:185-9.
33. Nienhuis HL, K. de Leeuw K, Bijzet J, Smit A, Schalkwijk CG, Graaff R, Kallenberg CG, Bijl M. Skin autofl uorescence is increased in systemic lupus erythematosus but is not refl ected by elevated plasma levels of AGE. Rheumatology 2008;47:1554-8.
34. Germanová A, Kouck ý M, Há j ek Z, Par?iý zek A, Zima T,Kalousov á M. Soluble receptor for adVanced glycation end products in physiological and pathological pregnancy.Clin Biochem 2010;43:442-6.
35. Há j ek Z, Kouck ý M, Zima T, Kopeck ý P, V iýtková M, Pariýzek A, Kalousov á M. Detection of feto-maternal infection/ infl ammation by the soluble receptor for adVanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008;36:339-404.
36. Chavakis T, Bierhaus A, Al-Fakhri N, SchneiDer D, Witte S,Linn T, Nagashima M, Morser J, Arnold B, Preissner KT,Nawroth PP. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for infl ammatory cell recruitment. J Exp Med 2003;198:1507-15
37. Pullerits R, Brisslert M, Jonsson IM, Tarkowski A. sRAGE triggers a proinfl ammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum 2006;54:3898-907.
38. Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S,Okamoto H, Watanabe T, Yamamoto H. Novel splice variants of the receptor for adVanced glycation end-products expressed in human vascular endothelial cells and pericytes,and their putative roles in diabetes-induced vascular injury.Biochem J 2003;370:1097-109.
39. Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P,Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C. Circulating soluble receptor of adVanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. Kidney Int 2010;77:225-31.
40. Babazoni T, Hanai K, Suzuki K, Kiuchi Y, Inoue A, Tanaka M, Hase M, Ishii A, Iwamoto Y. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia 2006;49:1387-93.